Plaintiffs say PxDx used automated code matching to deny claims without a doctor's individualized clinical review. A November 9 order gives Cigna until November 20 to request that exhibits remain sealed; certification has been requested, not granted.
Health insurer Cigna faces a proposed class plaintiffs estimate at more than 3 million members over PxDx, automated code matching they say denies claims without a doctor's individualized clinical review. “We literally click and submit,” a former Cigna doctor told ProPublica in its 2023 investigation. In a November 9 order, U.S. District Judge Dale A. Drozd of the Eastern District of California gave Cigna more time to ask that exhibits remain sealed. Cigna may submit that request by November 20. The larger fight is whether plaintiffs can challenge Cigna's alleged PxDx practice across a proposed class.
Cigna has contested a basic part of the plaintiffs' account. In an October 2024 court filing, it argued that a sworn affidavit from Cigna medical director Dr. Kessel showed that three plaintiffs named at the time had not had claims denied through PxDx. The current motion asks the judge to certify, or approve for litigation together, a nationwide class under ERISA, the federal employee-benefit law, and a separate California class.
The 6 sources behind this story: 5 court records and 1 other source, each linked with what it shows. Free with the weekly Litigation Sentinel brief.
The plaintiffs' motion describes a rigid list of matched codes, batch sign-off and a template denial letter. It alleges that Cigna substituted PxDx's automated code matching for the medical-necessity review required by members' plans. Plaintiffs say the same alleged practice can be judged across members without first deciding whether each person's treatment should have been covered.
One named claim gives that theory a person and a procedure. The motion alleges that Cigna used PxDx to deny named plaintiff Michael Mahshigian's claim for anesthesia during treatment for chronic spinal pain. The plaintiffs say no doctor meaningfully reviewed that claim when PxDx denied it.
Plaintiffs' motion estimates more than 3 million potential members of the nationwide class. ProPublica reported in 2023 that Cigna doctors denied more than 300,000 payment requests through the method it investigated over two months, averaging 1.2 seconds per case. The motion cites that reporting.
Free weekly intelligence for executives responsible for litigation exposure: the named decision-makers, dollar exposure, operating consequence, and next development.
Cigna's 2024 reply attacked whether three named plaintiffs had experienced the very PxDx denials they challenged. The new motion presses a wider proposition: whether proof about PxDx's design and operation can answer common questions for the proposed nationwide class. Plaintiffs ask for an order changing the alleged practice and for reprocessing of affected claims. They say disgorgement, the surrender of alleged gains, can be measured across the class rather than by calculating each member's potential benefits after an individual medical necessity review.
The motion seeks a separate California class under the state's unfair competition law that plaintiffs say has more than 1.4 million members. That proposed class raises questions about physician review, denial notices and what members were told about PxDx. Before the certification filing, the court allowed longer briefs for the two proposed classes.
This week's order concerns that evidence. Cigna told the court that plaintiffs filed 77 exhibits with the certification motion, that all but four were filed under seal, and that the volume was greater than it anticipated. It said it needed more time to prepare its sealing request and supporting declarations. Judge Drozd extended the deadline to November 20.
**The P&L translation:** plaintiffs seek class-wide remedies tied to Cigna's alleged PxDx practice, including reprocessing and surrender of alleged gains. The decision for a legal department this week is whether any automated rule it runs issues denials without individualized review, the practice plaintiffs challenge in the certification motion. **The Sentinel view:** Judge Drozd will certify at least one class, because one body of evidence can show whether doctors individually reviewed PxDx denials.
**The leading indicator:** how many of the 73 exhibits filed under seal Cigna asks to keep sealed by the November 20 deadline in the new order: all, some or none. The motion lists April 5, 2027, as the hearing date on whether one process can answer for the more than 3 million members plaintiffs propose.
The readiness check has five questions about your reported litigation practices. Use the summary to choose an operating question to explore.
Take the 2-minute readiness check →Free weekly intelligence for executives responsible for litigation exposure: the named decision-makers, dollar exposure, operating consequence, and next development.